These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18421580)

  • 1. Androgen deficiency: effects on body composition.
    Miller KK
    Pituitary; 2009; 12(2):116-24. PubMed ID: 18421580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
    J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and the ageing male and female.
    Yialamas MA; Hayes FJ
    Best Pract Res Clin Endocrinol Metab; 2003 Jun; 17(2):223-36. PubMed ID: 12787549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men.
    Tenover JS
    Baillieres Clin Endocrinol Metab; 1998 Oct; 12(3):419-25. PubMed ID: 10332563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen effect on body composition and fat metabolism.
    Jensen MD
    Mayo Clin Proc; 2000 Jan; 75 Suppl():S65-8; discussion S68-9. PubMed ID: 10959220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone, body composition and aging.
    Vermeulen A; Goemaere S; Kaufman JM
    J Endocrinol Invest; 1999; 22(5 Suppl):110-6. PubMed ID: 10442580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen effects on body composition.
    Bhasin S; Woodhouse L; Storer TW
    Growth Horm IGF Res; 2003 Aug; 13 Suppl A():S63-71. PubMed ID: 12914730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone action on skeletal muscle.
    Herbst KL; Bhasin S
    Curr Opin Clin Nutr Metab Care; 2004 May; 7(3):271-7. PubMed ID: 15075918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?
    Bhasin S; Javanbakht M
    JPEN J Parenter Enteral Nutr; 1999; 23(6 Suppl):S195-201. PubMed ID: 10571455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
    JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
    Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA; Boneva Z; Christov VG
    Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center study.
    Wang C; Eyre DR; Clark R; Kleinberg D; Newman C; Iranmanesh A; Veldhuis J; Dudley RE; Berman N; Davidson T; Barstow TJ; Sinow R; Alexander G; Swerdloff RS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3654-62. PubMed ID: 8855818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial.
    Kralik M; Cvecka J; Buzgo G; Putala M; Ukropcova B; Ukropec J; Killinger Z; Payer J; Kollarik B; Bujdak P; Raastad T; Sedliak M
    BMJ Open; 2019 Sep; 9(9):e025991. PubMed ID: 31492775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.
    Hayes VY; Urban RJ; Jiang J; Marcell TJ; Helgeson K; Mauras N
    J Clin Endocrinol Metab; 2001 May; 86(5):2211-9. PubMed ID: 11344229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.